1. Home
  2. TURN vs GRCE Comparison

TURN vs GRCE Comparison

Compare TURN & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TURN
  • GRCE
  • Stock Information
  • Founded
  • TURN 1981
  • GRCE 2002
  • Country
  • TURN United States
  • GRCE United States
  • Employees
  • TURN N/A
  • GRCE N/A
  • Industry
  • TURN Finance/Investors Services
  • GRCE
  • Sector
  • TURN Finance
  • GRCE
  • Exchange
  • TURN Nasdaq
  • GRCE NYSE
  • Market Cap
  • TURN 39.6M
  • GRCE 35.6M
  • IPO Year
  • TURN N/A
  • GRCE N/A
  • Fundamental
  • Price
  • TURN $3.96
  • GRCE $3.48
  • Analyst Decision
  • TURN
  • GRCE
  • Analyst Count
  • TURN 0
  • GRCE 0
  • Target Price
  • TURN N/A
  • GRCE N/A
  • AVG Volume (30 Days)
  • TURN 42.8K
  • GRCE 131.8K
  • Earning Date
  • TURN 02-25-2025
  • GRCE 02-21-2025
  • Dividend Yield
  • TURN N/A
  • GRCE N/A
  • EPS Growth
  • TURN N/A
  • GRCE N/A
  • EPS
  • TURN N/A
  • GRCE N/A
  • Revenue
  • TURN $129,297.00
  • GRCE N/A
  • Revenue This Year
  • TURN N/A
  • GRCE N/A
  • Revenue Next Year
  • TURN N/A
  • GRCE N/A
  • P/E Ratio
  • TURN N/A
  • GRCE N/A
  • Revenue Growth
  • TURN 6.32
  • GRCE N/A
  • 52 Week Low
  • TURN $3.12
  • GRCE $2.13
  • 52 Week High
  • TURN $4.47
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • TURN 59.25
  • GRCE N/A
  • Support Level
  • TURN $3.85
  • GRCE N/A
  • Resistance Level
  • TURN $4.05
  • GRCE N/A
  • Average True Range (ATR)
  • TURN 0.14
  • GRCE 0.00
  • MACD
  • TURN -0.01
  • GRCE 0.00
  • Stochastic Oscillator
  • TURN 74.36
  • GRCE 0.00

About TURN 180 Degree Capital Corp.

180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: